ArticleEFSA journal. European Food Safety Authority2026
Assessment of additional information related to genetically modified oilseed rape MS11 (application EFSA-GMO-BE-2016-138).
Article in EFSA journal. European Food Safety Authority, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Assessment of additional information related to genetically modified oilseed rape MS11 (application EFSA-GMO-BE-2016-138).EFSA journal. European Food Safety Authority · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
23 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In a previous scientific opinion on application EFSA-GMO-BE-2016-138, the EFSA Panel on Genetically Modified Organisms (GMO Panel) could not conclude on the comparative analysis and on the food and feed safety assessment of genetically modified (GM) oilseed rape MS11 because of the lack of an appropriate compositional data set. Following a request from the European Commission, the GMO Panel assessed additional information on the composition of oilseed rape MS11. The GMO Panel concluded that the information can be used to complement the original assessment. None of the differences identified in seed composition between oilseed rape MS11 and the conventional counterpart needed further assessment regarding food and feed safety. The GMO Panel found no evidence that the genetic modification impacts the overall safety of oilseed rape MS11. Τhe consumption of oilseed rape MS11 does not represent any nutritional concern. Νo post-market monitoring of food and feed is considered necessary. Considering the assessment reported in the original scientific opinion and in this statement, the GMO Panel concludes that oilseed rape MS11 is as safe as its conventional counterpart and the tested non-GM oilseed rape reference varieties with respect to potential effects on human and animal health and the environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.